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Protein O-fucosylation is an important post-translational modification (PTM)
found in cysteine-rich repeats in proteins. Protein O-fucosyltransferases 1 and 2
(PoFUT1 and PoFUT2) are the enzymes responsible for this PTM and
selectively glycosylate specific residues in epidermal growth factor-like (EGF)
repeats and thrombospondin type I repeats (TSRs), respectively. Within the past
six years, crystal structures of both enzymes have been reported, revealing
important information on how they recognize protein substrates and achieve
catalysis. Here, the structural information available today is summarized and
how PoFUT1 and PoFUT2 employ different catalytic mechanisms is discussed.
1. Introduction
Fucose is an important biological sugar that can be found as
part of various glycoconjugates and is one of the two mono-
saccharides present in mammals with an l-configuration
(Bertozzi & Rabuka, 2009). Fucose modifications of proteins,
mostly known asO-fucosylation, play multiple roles in cellular
events. In mammals, there are 13 glycosyltransferases (GTs)
that are capable of adding a fucose residue using GDP-fucose
as the sugar donor, but only two GTs, protein O-fucosyl-
transferases 1 and 2 (PoFUT1 and PoFUT2), can directly
glycosylate protein side chains (Schneider et al., 2017). Both
PoFUT1 and PoFUT2 transfer fucose from GDP-fucose to
serine or threonine residues in cysteine-rich repeats in
proteins. However, while PoFUT1 glycosylates epidermal
growth factor-like (EGF) repeats within the consensus
sequence C2-X-X-X-X-S/T-C3 (Haltom & Jafar-Nejad, 2015),
PoFUT2 glycosylates thrombospondin type I repeats (TSRs)
containing Ser/Thr residues located in the consensus
sequences C1-X-X-S/T-C2 or C2-X-X-S/T-C3 of TSRs of groups
1 and 2 (see below), respectively (Schneider et al., 2017).
EGF repeats are small domains ranging between 30 and 40
amino acids, characterized by the formation of three disulfide
bridges with the arrangement C1–C3, C2–C4 and C5–C6
(Savage et al., 1973). TSRs are larger than EGF repeats (60
amino acids) and can be split into two groups owing to their
disulfide-bridge arrangement. The disulfide bridges of group 1
TSR are arranged as C1–C5, C2–C6 and C3–C4, while TSRs of
group 2 adopt the pattern C1–C4, C2–C5 and C3–C6 (Leonhard-
Melief & Haltiwanger, 2010). Although the disulfide-bridge
arrangement differs between the two groups, the C2–C6 and
C3–C6 disulfide bridges are conserved (Leonhard-Melief &
Haltiwanger, 2010). PoFUT1 and PoFUT2 both require
correctly folded repeats for O-fucosylation to take place (Luo,
Nita-Lazar et al., 2006; Wang & Spellman, 1998) and both
isoforms are highly selective for each repeat (Luo, Koles et al.,
ISSN 2053-230X
2006; Luo, Nita-Lazar et al., 2006), suggesting that the different
disulfide-bridge arrangements and consensus sequences are
essential features for substrate recognition. This review
outlines recent progress in unveiling the differences in the
reaction mechanisms and protein-substrate recognition of
these enzymes, and the importance of O-fucosylation in
protein–protein interaction.
2. PoFUT1 and PoFUT2 protein substrates
The first substrate of PoFUT1 to be identified was the urinary
type 1 plasminogen activator (Kentzer et al., 1990). Now,
approximately 100 proteins with EGF repeats are predicted to
be O-fucosylated, although only a few have been confirmed
(for a thorough review, see Schneider et al., 2017). The Notch
receptors, which are transmembrane type I proteins that form
part of the Notch signalling pathway, are the most studied
PoFUT1 substrates. Most of the EGF repeats present in the
four Notch receptors found in mammals enclose the consensus
sequence required forO-fucosylation by PoFUT1 (Takeuchi &
Haltiwanger, 2014). Notch ligands, two in Drosophila (Delta
and Serrate) and three Delta-like and two Serrate-like ligands
in mammals (Dll1, Dll3, Dll4, Jagged1 and Jagged2; D’Souza et
al., 2008), also contain EGF repeats that can be O-fucosylated
by PoFUT1 (Schneider et al., 2017).
Notch glycosylation is an elegant example of how the cell
uses protein glycosylation to tune signalling-pathway activity.
The elongation of Notch1 O-fucose by the addition of an
N-acetylglucosamine (GlcNAc) moiety by Fringe GTs directs
the specificity of the Notch receptors towards Delta and
reduces Notch activation by Jagged proteins (Xu et al., 2007).
Recent crystallographic complexes between Notch1 and its
ligands (DLL4 and Jagged) show that the fucose moiety also
plays an essential role in ligand interaction (Luca et al., 2015,
2017). The O-fucose moiety at Notch1 EGF12 Thr466
contributes significantly to recognizing DLL4 by hydrogen-
bonding and hydrophobic interactions with the DLL4 MNNL
domain (module at the N-terminus of the Notch ligand;
Fig. 1a; Luca et al., 2015). However, the complex between
Notch1 and Jagged1 is stabilized by interactions between
Notch1 EGF12 Thr466-O-fucose and the Jagged1 C2 domain
and also between Notch1 EGF8 Thr311-O-fucose and Jagged1
EGF3 (Fig. 1b). These interactions between Jagged1 and
Notch1 provide an explanation of why Jagged1 binds sixfold
more tightly to Notch1 EGFs 8–12 than a construct containing
only EGFs 11–12 (Luca et al., 2017). Notch signalling plays a
significant role in cell development, and its malfunction can
lead to several diseases, including various types of cancer
(Allenspach et al., 2002). The glycosylation of Notch receptors
may also play a role in aberrant signalling (Takeuchi &
Haltiwanger, 2014), and in this sense it has been reported that
PoFUT1 is overexpressed in some cancer types (Kroes et al.,
2007; Loo et al., 2013; Yokota et al., 2013).
Despite the prediction of more than 50 protein substrates,
very little is known about the TSR O-fucose function
(Schneider et al., 2017). The first O-fucosylated TSRs
described in the literature were found on thrombospondin-1
(TSP1; Hofsteenge et al., 2001). Subsequently, PoFUT2 was
isolated and characterized, following the realization that
PoFUT1 does not glycosylate TSRs (Luo, Nita-Lazar et al.,
2006; Luo, Koles et al., 2006). ADAMT and ADAMT-like
proteins are a large family of proteins that are predicted to
have several TSRs that are potentially O-fucosylated by
PoFUT2 (Kelwick et al., 2015; Schneider et al., 2017), and
O-fucose is a requirement for the efficient secretion of some of
these proteins (Ricketts et al., 2007; Wang et al., 2007; Vasu-
devan et al., 2015; Benz et al., 2016). Very recently, it has been
reported that depletion of PoFUT2 in Plasmodium falciparum
results in attenuated infection of the mosquito vector and
human hepatocytes. The authors concluded that this effect was
owing to the loss of trafficking of PoFUT2 target proteins
(Lopaticki et al., 2017).
3. The PoFUT1/2 GDP-fucose binding site is highly
conserved
The first reported crystal structures of protein O-fucosyl-
transferases were those of Caenorhabditis elegans PoFUT1
(CePoFUT1) in the unliganded form (PDB entry 3zy4) and in
complex with GDP and GDP-fucose (PDB entries 3zy3 and
3zy6) (Lira-Navarrete et al., 2011). The human PoFUT1
(HsPoFUT1) crystal structure was reported in the free form
and in the presence of GDP-fucose (PDB entries 5ux6 and
5uxh; Li et al., 2017), and crystal structures of Mus musculus
PoFUT1 (MmPoFUT1) in complex with different EGF
repeats (PDB entries 5kxh, 5ky0, 5ky2, 5ky3, 5ky4, 5ky5, 5ky7,
5ky8 and 5ky9) have also been reported (Li et al., 2017).
Regarding PoFUT2, there are two crystal structures available
for human PoFUT2: in the free form and complexed with
GDP-fucose (PDB entries 4ap5 and 4ap6; Chen et al., 2012).
In addition, the ternary complex between CePoFUT2, GDP
and the human TSR1 (HsTSR1) repeat (PDB entry 5foe) has
been described. Note that the latter complex is the only
structure of PoFUT2 known to include an acceptor-protein
substrate (Valero-Gonza´lez et al., 2016).
Both PoFUT1 and PoFUT2 present the typical GT-B fold,
which consists of two Rossmann-like domains facing each
other with the active site lying within the resulting deep cleft
formed between them (Fig. 2a; Lairson et al., 2008). Although
both enzymes share the same type of folding, the super-
imposition of apo forms of human PoFUT1 and PoFUT2
renders a poor root-mean-square deviation (r.m.s.d.) on 174
equivalent C atoms of 3.03 A˚ (Fig. 2b), which is in agreement
with the observed low sequence identity (28% identity). This
difference between the HsPoFUT1 and HsPoFUT2 crystal
structures is mainly attributed to the presence of two promi-
nent loops in HsPoFUT2 that are absent in HsPoFUT1. While
loop260–287 is located in the C-terminal domain with no
apparent function in catalysis, loop141–155 contributes to the
formation of the cleft in which the acceptor substrate is
located (Fig. 2b). HsPoFUT1 also has additional secondary
elements that are formed by residues Ser243–Leu284, which
encompass three -helices and a 310-helix (Fig. 2b). This
region prevents the exposure of GDP-fucose to the solvent
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and avoids the binding of a TSR. Similarly, HsPoFUT2
employs loop141–155 to selectively bind TSRs in contraposition
to EGF repeat acceptor substrates (Valero-Gonza´lez et al.,
2016; Li et al., 2017). Superimposition of both human enzymes
complexed with GDP-fucose renders an r.m.s.d. on 167
equivalent C atoms of 2.62 A˚, suggesting a higher fold
similarity of the enzymes in the presence of the sugar donor in
contrast to the free form.
For both enzymes, most of the residues involved in inter-
action with GDP-fucose are conserved. The essential residues
Arg240HsPoFUT1/Arg294HsPoFUT2 interact with the -phosphate
of GDP-fucose through hydrogen-bonding and electrostatic
topical reviews
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Figure 1
Importance of Notch fucosylation for ligand interaction. (a) Surface and cartoon representations of the Notch1–DLL4 complex (PDB entry 4xl1; Luca et
al., 2015). Notch1 EGFs 11–13 are shown in green and the MNNL-DSL-EGF1 Delta domains are shown in pink. The fucose (orange) modification of
Notch1 Thr466 and its interactions with DLL4 residues are depicted in the left panel. (b) Surface and cartoon representation of the Notch1–Jagged1
complex (PDB entry 5uk5; Luca et al., 2017). Notch 1 EGFs 8–12 are shown in green, the C2-DSL-EGF1–3 Jagged domains are shown in red and Notch
fucose is shown in orange. The interactions of the Notch1 fucose modifications of Thr466 and Thr311 are depicted in the upper and lower panels,
respectively. Ca2+ ions are shown as green spheres.
interactions, which are conserved in other fucosyltransferases
(Martinez-Duncker et al., 2003; Okajima et al., 2005; Lira-
Navarrete et al., 2011; Chen et al., 2012; McMillan et al., 2017).
The GDP moiety is tethered by additional interactions with
Asn46/Asn57, His238/His292, Asp340/Asp371, Ser356/Ser387,
Ser357/Thr388 and Phe358/Phe389 of HsPoFUT1 and
HsPoFUT2, respectively (Fig. 3). GDP also interacts with the
backbones of Phe44 and Gly45 in HsPoFUT1. Contrary to the
high level of conservation between the interacting residues of
HsPoFUT1 andHsPoFUT2 with the GDPmoiety, the residues
recognizing the fucose moiety are not conserved. In particular,
the fucose moiety is stabilized by interactions with Arg43/
Asp244 ofHsPoFUT1 and Pro53/Gly55 ofHsPoFUT2 (Fig. 3).
4. PoFUT1 and PoFUT2 deploy different strategies for
protein-substrate recognition
The structures of both enzymes in complex with acceptor
substrates highlight significant differences. Complexes
between MmPoFUT1 and four different EGF repeats reveal
that the binding mode of all repeats is preserved (Li et al.,
2017). The EGF repeats locate near a hairpin formed by amino
acids Val72–Ser91, which are highly conserved among
different species (Lira-Navarrete et al., 2011). This particular
hairpin moves to maintain contact with the EGF C5–C6
subdomain through hydrophobic interactions with residues
His80 or Phe85 (Li et al., 2017). Other conserved interactions
are made byMmPoFUT1 residues Phe266 and Met267 and an
apolar residue located next to the fourth cysteine in the EGF
repeats (Fig. 4a; Li et al., 2017). Finally, primary interactions
between MmPoFUT1 and the different EGF repeats are
formed by amino acids from the inner part of theMmPoFUT1
groove and the EGF consensus sequence. Within the
consensus sequence, the hydrogen-bond interaction between
the acceptor Ser/Thr and Asn51MmPoFUT1 is of the utmost
importance for catalytic purposes (Li et al., 2017).
Looking at the CePoFUT2–GDP–HsTSR1 ternary
complex, it is evident that both the interactions between the
topical reviews
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Figure 2
(a) Cartoon representations of the human PoFUT1 (PDB entry 5ux6; McMillan et al., 2017) and PoFUT2 (PDB entry 4ap5; Chen et al., 2012) structures.
Secondary structures are shown forHsPoFUT1 with helices in cyan and -sheets in salmon; forHsPoFUT2 helices are shown in slate blue and -sheets in
magenta. (b) Superimposed structures of HsPoFUT1 (cyan) and HsPoFUT2 (slate blue). Main secondary-structure differences are highlighted in boxes.
CePoFUT2–HsTSR1 and MmPoFUT1–EGF complexes and
the arrangement of the TSR and EGF repeats differ (Valero-
Gonza´lez et al., 2016; Li et al., 2017). The CePoFUT2–HsTSR1
complex is partly supported by direct interactions between
two hydrophobic patches of CePoFUT2 and nonconserved
residues of HsTSR1 (Fig. 4b). Three of the ten direct inter-
actions between CePoFUT2 and HsTSR1 are conserved for
other TSRs, suggesting that the complex is stabilized by a
limited number of direct interactions. Within these three
interactions, the hydrogen bond between the acceptor Ser or
Thr and the catalytic base Glu52 is essential for catalysis
(Valero-Gonza´lez et al., 2016).
A striking difference between the MmPoFUT1–EGF and
CePoFUT2–HsTSR1 complexes is the large number of water
molecules that are present in the interface of the latter. These
water molecules mediate an important number of interactions
through hydrogen bonds between the enzyme and HsTSR1
(Fig. 4b; Valero-Gonza´lez et al., 2016). The interactions
provide an explanation at the molecular level of how PoFUT2
recognizes multiple dissimilar TSRs (Leonhard-Melief &
Haltiwanger, 2010; Kakuda & Haltiwanger, 2014). Therefore,
both PoFUT1 and PoFUT2 deploy different strategies to
identify their acceptor-protein substrates. PoFUT2 recognizes
TSRs by using a limited number of direct conserved inter-
actions complemented by a large number of hydrogen-bond
interactions mediated by water molecules (Valero-Gonza´lez et
al., 2016). Meanwhile, PoFUT1 uses a water-filled cavity to
accommodate the EGF loop C1–C2 (Li et al., 2017), although
the main interactions rely on conserved direct hydrogen bonds
between the enzyme and its protein substrate.
5. Catalytic mechanisms of PoFUT1 and PoFUT2
The ternary complexes also provided a better understanding
of how the two enzymes achieve catalysis. These proteins are
inverting GTs, implying that the acceptor Ser/Thr makes a
nucleophilic attack on the nucleotide sugar anomeric C atom
from the opposite side to the leaving nucleotide. As a result,
this action inverts the anomeric stereochemistry (Lairson et
al., 2008). In this mechanism, deprotonation of the acceptor
hydroxyl group by a catalytic base, usually an aspartate or a
glutamate, is required to increase the nucleophilic character of
the acceptor residue and is a prior step to the attack of the
acceptor on the anomeric C atom (Lairson et al., 2008; Breton
et al., 2012). While an amino acid acting as a catalytic base is
present in PoFUT2 (Glu54/Glu52 in human PoFUT2 and
CePoFUT2, respectively), an equivalent residue is not found
in PoFUT1. As expected, mutating Glu54 and Arg294 in
HsPoFUT2 revealed that these two amino acids are essential
for catalytic activity (Chen et al., 2012). Furthermore, the
CePoFUT2–GDP–HsTSR1 complex, together with molecular
dynamics, supports the role of a glutamate as the catalytic
base. In this crystal structure, Glu52 was engaged in a
hydrogen bond to the acceptor serine in the HsTSR1 repeat
(Valero-Gonza´lez et al., 2016). Overall, these data support an
SN2-like mechanism for PoFUT2 (Fig. 5b), which is the typical
mechanism reported for most inverting glycosyltransferases
(Lairson et al., 2008).
In contrast, an SN1-like mechanism was proposed for
PoFUT1 (Fig. 5a) in which Asn43 of CePoFUT1 positions the
incoming acceptor and Arg240 facilitates the cleavage of the
glycosidic bond by interacting with the -phosphate group
(Lira-Navarrete et al., 2011). Michaelis complexes of
MmPoFUT1 also support an SN1-like mechanism and confirm
a similar arrangement as above. The equivalent residues in
MmPoFUT1, Asn51 and Arg245, are engaged in hydrogen
bonds to the acceptor residue and the -phosphate group,
respectively. Arg240CePoFUT1/Arg245MmPoFUT1 could also
favour the reaction by stabilizing GDP. In addition, the
acceptor hydroxyl group is close to a water molecule that is
engaged in a hydrogen bond to the -phosphate O atom. In
concordance with an SN1-like mechanism, this water molecule
topical reviews
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Figure 3
Comparison of the GDP-fucose binding site in (a)HsPoFUT1 (PDB entry 5uxh; McMillan et al., 2017) and (b)HsPoFUT2 (PDB entry 4ap6; Chen et al.,
2012). GDP-fucose is shown in stick representation with orange C atoms. Amino acids of HsPoFUT1 and HsPoFUT2 that interact with GDP-fucose are
represented as sticks with cyan and slate blue C atoms, respectively.
could promote catalysis by providing a proton relay serving to
shuttle the acceptor hydroxyl proton to the GDP -phosphate
O atom, which acts as the catalytic base (Li et al., 2017). This
reaction mechanism of PoFUT1 differs from that proposed for
topical reviews
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Figure 4
Comparison of the PoFUT1 and PoFUT2 acceptor-binding sites. (a) Left: cartoon representation of MmPoFUT1 (cyan) in complex with MmEGF26
(salmon) and GDP (depicted as sticks with orange C atoms; PDB entry 5ky4; Li et al., 2017). Right: close-up view of the EFG binding site. The interacting
amino acids of MmPoFUT1 and MmEGF26 are shown as sticks with cyan and salmon C atoms, respectively. (b) Left: cartoon representation of
CePoFUT2 (slate blue) in complex withHsTSR1 (magenta) and GDP (sticks with orange C atoms; PDB entry 5foe; Valero-Gonza´lez et al., 2016). Upper
right box: close-up view of the TSR binding site. C atoms of interacting residues are shown as sticks in slate blue (CePoFUT2) and magenta (HsTSR1).
Lower right box: close-up view of the TSR binding site rotated 95 around the z axis and 35 around the y axis. Amino-acid colours are the same as in the
upper panel and water molecules are shown as red spheres.
PoFUT2, and consists of prior cleavage of the glycosidic bond,
followed by attack of the pre-activated acceptor hydroxyl
group on the anomeric C atom.
6. Final remarks
PoFUT1 and PoFUT2 are glycosyltransferases that share great
resemblances, including catalysis of the same type of PTM,
architecture and the recognition of proteins with cysteine-rich
repeats (Chen et al., 2012; Schneider et al., 2017). However,
significant differences are present at the primary-structure and
secondary-structure levels, accounting for the different
arrangements of EGF repeats and TSRs in the binding site,
the recognition mode of EGF repeats and TSRs, and the
reaction mechanism. These differences explain why these
enzymes serve specific substrates and are not capable of cross-
recognizing their acceptor substrates. PoFUT2 has evolved to
glycosylate two different groups of TSRs (Kakuda & Halti-
wanger, 2014). In doing so, PoFUT2 employs a different
strategy to recognize its TSRs by using a water-molecule
network that mediates enzyme–protein substrate interactions
(Valero-Gonza´lez et al., 2016). In addition, while the SN2-like
mechanism of PoFUT2 is well accepted for inverting GTs, the
atypical SN1-like mechanism proposed for PoFUT1 needs
further validation by additional experiments.
We expect that these findings will be able to be leveraged
for the development of inhibitors/modulators of PoFUT1/2
that would be useful for providing further insights into the role
of this PTM in animal models and for diseases and pathologies
associated with these enzymes.
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